CA
TMO icon

Claro Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Claro Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$387K Buy
788
+17
+2% +$9.23K 0.05% 303
2025
Q4 		$447K Buy
771
+40
+5% +$22.6K 0.06% 247
2025
Q3 		$355K Sell
731
-7
-0.9% -$3.26K 0.05% 285
2025
Q2 		$299K Sell
738
-284
-28% -$119K 0.05% 293
2025
Q1 		$508K Buy
1,022
+122
+14% +$66.1K 0.07% 260
2024
Q4 		$468K Sell
900
-399
-31% -$219K 0.06% 256
2024
Q3 		$804K Buy
1,299
+558
+75% +$330K 0.1% 191
2024
Q2 		$410K Buy
741
+148
+25% +$84.8K 0.06% 261
2024
Q1 		$345K Buy
+593
New +$333K 0.06% 296
2019
Q1 		– Sell
-146
Closed -$36K – 855
2018
Q4 		$36K Buy
+146
New +$34.3K 0.03% 408

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Claro Advisors's TMO Position: Q1 2026 in Review

Claro Advisors increased its Thermo Fisher Scientific (TMO) stake by 2.2% in Q1 2026, buying an estimated $9.23K and bringing the position to 788 shares worth $387K. The position accounts for 0.05% of the portfolio, ranked #303.

Claro Advisors first reported a position in TMO in Q4 2018 and has held it in 10 quarters since. The position peaked at $804K in Q3 2024. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Claro Advisors held 788 shares of Thermo Fisher Scientific worth $387K as of Q1 2026.
  • Claro Advisors bought 17 Thermo Fisher Scientific shares in Q1 2026, an estimated $9.23K.
  • Thermo Fisher Scientific made up 0.05% of Claro Advisors's portfolio in Q1 2026, its #303 holding.
  • Claro Advisors first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 10 quarters since.
  • Claro Advisors's Thermo Fisher Scientific position peaked at $804K in Q3 2024.
  • 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Claro Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.